Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: Potential utility of immunosuppressive therapy in cardiac damage progression

Agostino Meduri, Filippo Crea, Maurizio Pieroni, Maria De Santis, Gaetano Zizzo, Silvia Laura Bosello, Costantino Smaldone, Mara Campioni, Giacomo De Luca, Antonella Laria, Fulvio Bellocci, Lorenzo Bonomo, Gianfranco Ferraccioli

Risultato della ricerca: Contributo in rivistaArticolo in rivista

81 Citazioni (Scopus)

Abstract

Scleroderma heart disease is a major risk of death in systemic sclerosis (SSc). Mechanisms underlying myocardial damage are still unclear. We performed an extensive study of SSc patients with recent-onset symptoms for heart disease and examined the efficacy of immunosuppressive therapy.
Lingua originaleEnglish
pagine (da-a)526-535
Numero di pagine10
RivistaSEMINARS IN ARTHRITIS AND RHEUMATISM
Volume43
DOI
Stato di pubblicazionePubblicato - 2013

Keywords

  • ANCA
  • Heart disease
  • Myocarditis
  • Parvovirus B19
  • Systemic sclerosis
  • Treatment

Fingerprint

Entra nei temi di ricerca di 'Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: Potential utility of immunosuppressive therapy in cardiac damage progression'. Insieme formano una fingerprint unica.

Cita questo